THE EFFICACY OF ECULIZUMAB IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

被引：0
|
作者：
Matsumura, D. [1 ]
Sato, E. [1 ]
Lu, H. [1 ]
Nomura, M. [1 ]
Amaha, M. [1 ]
Fujii, A. [2 ]
Ono, Y. [2 ]
Ueda, Y. [2 ]
Nakamura, T. [1 ]
机构：
[1] Shinmatsudo Cent Gen Hosp, Matsudo, Chiba, Japan
[2] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Japan
来源：
NEPHROLOGY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
283
引用
下载
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF ECULIZUMAB IN ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) PATIENTS WITH OR WITHOUT PRIOR TRANSPLANT
    Legendre, Christophe
    Cohen, David
    Delmas, Yahsou
    Feldkamp, Thorsten
    Fouque, Denis
    Furman, Richard
    Gaber, Osama
    Greenbaum, Larry
    Goodship, Timothy
    Haller, Hermann
    Herthelius, Maria
    Hourmant, Maryvonne
    Licht, Christoph
    Moulin, Bruno
    Sheerin, Neil
    Trivelli, Antonella
    Bedrosian, Camille L.
    Loirat, Chantal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 309 - 309
  • [2] Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan
    Ito, Naoko
    Hataya, Hiroshi
    Saida, Ken
    Amano, Yoshiro
    Hidaka, Yoshihiko
    Motoyoshi, Yaeko
    Ohta, Toshiyuki
    Yoshida, Yasuhiro
    Terano, Chikako
    Iwasa, Tadashi
    Kubota, Wataru
    Takada, Hidetoshi
    Hara, Toshiro
    Fujimura, Yoshihiro
    Ito, Shuichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (02) : 265 - 272
  • [3] Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan
    Naoko Ito
    Hiroshi Hataya
    Ken Saida
    Yoshiro Amano
    Yoshihiko Hidaka
    Yaeko Motoyoshi
    Toshiyuki Ohta
    Yasuhiro Yoshida
    Chikako Terano
    Tadashi Iwasa
    Wataru Kubota
    Hidetoshi Takada
    Toshiro Hara
    Yoshihiro Fujimura
    Shuichi Ito
    Clinical and Experimental Nephrology, 2016, 20 : 265 - 272
  • [4] A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
    Azarfar, Anoush
    Sabbagh, Mahin Ghorban
    Ravanshad, Yalda
    Esmaeeli, Mohammad
    Mehrad-Majd, Hassan
    Sani, Azade Oveisi
    Ravanshad, Sahar
    JOURNAL OF RENAL INJURY PREVENTION, 2019, 8 (02): : 116 - 121
  • [5] EFFICACY OF ECULIZUMAB IN ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) PATIENTS WITH OR WITHOUT A HISTORY OF DIALYSIS
    Legendre, Christophe
    Babu, Sunil
    Cohen, David
    Delmas, Yahsou
    Furman, Richard
    Gaber, Osama
    Greenbaum, Larry
    Hourmant, Maryvonne
    Jungraithmayr, Therese
    Lebranchu, Yvon
    Riedl, Magdalena
    Sheerin, Neil
    Bedrosian, Camille L.
    Loirat, Chantal
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 309 - 309
  • [6] ECULIZUMAB IN SECONDARY ATYPICAL HEMOLYTIC UREMIC SYNDROME
    Cavero Escribano, Teresa
    Praga, Manuel
    de Cordoba, Santiago R.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [7] Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
    Rodriguez, Eva
    Barrios, Clara
    Jose Soler, Maria
    CLINICAL KIDNEY JOURNAL, 2017, 10 (03): : 320 - 322
  • [8] Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Amadio, Anthony
    Tejani, Aaron M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1378 - 1378
  • [9] Eculizumab cessation in atypical hemolytic uremic syndrome
    Merrill, Samuel A.
    Brittingham, Zachary D.
    Yuan, Xuan
    Moliterno, Alison R.
    Sperati, C. John
    Brodsky, Robert A.
    BLOOD, 2017, 130 (03) : 368 - 372
  • [10] ATYPICAL HEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB
    Khawar, M. U.
    Bhutta, U.
    Haragsim, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 410 - 410
12345